Definitive Healthcare Q2 revenue $63.7M (+5% YoY); net loss $(306.2)M on $363.6M goodwill impairment

Definitive Healthcare Corp.

2024-Q2 EPS reported -$1.90 revenue$127,217,000

Revenue $63.7M (+5% YoY); net loss $(306.2)M including $363.6M goodwill impairment (up 2,538% from $(11.6)M).
Adjusted EBITDA $20.9M (33% margin) vs $17.2M; Adjusted Net Income $14.2M vs $12.4M.
Enterprise customers grew 6% YoY to 537; cash from ops $14.0M, unlevered FCF $21.5M.
Q3 2024 guidance: revenue $61-62.5M; adj. EBITDA $17.5-19M. FY2024 revenue $247-251M; adj. EBITDA $74-77M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.